drugs
CT got fewer vaccines than other states, but did far better at getting people vaccinated
Download the report here Policymakers and experts have expressed disappointment at the slow rollout of the COVID-19 vaccines. While the vaccines were developed and manufactured at record speeds, getting Americans vaccinated has been slower than expected. The Secretary of Human Services expected to have 20 million Americans vaccinated by the end of 2020. But as…
Read MoreTop Stories of 2020
A year ago, our predictions for 2020 missed all but the recession. COVID has us giving up on predictions, so we’ll just take a look back at our top stories of this year. Advocacy Toolbox now online — Updates include specific, real world tools for legislative, administrative, and state budget advocacy, how to change public…
Read MoreICER seeking members for New England evidence review group
The Institute for Economic and Clinical Review (ICER) is seeking nominations for new members to the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). The Council includes leading clinicians, patient and consumer advocates, methodologists, and health economists. The group holds public meetings three to four times per year to discuss evidence reports on…
Read MoreCTNJ ANALYSIS | On Healthcare, Candidates Focused on Public Option, Medicare For All, Drug Prices
This year, Connecticut candidates running for office during a global pandemic and a harsh recession had thoughtful, well-informed answers to CTNewsJunkie‘s tough healthcare questions. One said, “The impact of the pandemic has brought the need for affordable health care into even sharper focus. Many people lost their health insurance when they lost their jobs .…
Read MoreUS safe injection sites could save lives and save cities up to $4.35 million each year
Allowing safe sites for injecting opioids in the US would save lives and lower healthcare spending significantly for affected communities, according to ICER’s latest draft evidence report. In 2018, opioid overdoses killed 948 Connecticut residents and there are signals that the rate has risen during the pandemic. Supervised injection facilities (SFIs) are part of a…
Read MoreHalf of Americans concerned about bankruptcy from a health event
A new Gallup poll from July finds that 50% of Americans were concerned that a health event in their household will result in bankruptcy. That is up from 45% last year. Concern is far higher among non-white than white adults (64% vs. 43%). One in seven American households (15%) has medical debt that they will…
Read MoreBook Club: Deaths of Despair and the Future of Capitalism
By Anne Case and Angus Deaton Reversing a century of progress, life expectancy has fallen for three years in a row but only in the US. Rising rates of suicide, drug overdoses and alcoholism are largely to blame. There were early media reports about the trend, but this detailed yet readable book goes much farther.…
Read MoreUpdate: OHS committee slightly eases unrealistic cap for CT healthcare costs
In response to stakeholder concerns, at their July 29th meeting the Office of Health Strategy’s (OHS) Technical Team choosing the cap for future Connecticut healthcare costs eased their previous decision on how much healthcare costs for every state resident will be allowed to increase over the next five years. Many stakeholders have voiced concerns that…
Read MoreCost Cap project could reduce access to care, stifle efficiency and innovation, and increase disparities
Download the Summary or Full Report Healthcare costs a lot in Connecticut, especially for middle and lower income residents. Primary care is the foundation of a healthy health system. Lowering costs and supporting primary care are important goals, however the Office of Health Strategy’s (OHS) new plan to limit costs is ill-conceived and likely to…
Read MoreProtecting affordability in a pandemic — Experts find fair prices for remdesivir between $10 and $4,500
In a nation hungry for good news in fighting the COVID-19 pandemic, remdesivir has emerged as a first ray of hope. The FDA has quickly approved the drug for emergency use with seriously ill patients. However there are concerns that the data supporting remdesivir’s effectiveness has not been published or peer reviewed by independent scientists…
Read More